Long‐term follow‐up of cervical cancer incidence after normal cytological findings
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34723 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Jiangrong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Uterine Cervical Dysplasia, Papillomavirus Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Cancer Foundation.
Abstract (Originalsprache)
An increase in cervical cancer incidence in Sweden from 2014 to 2015 has been attributed to an increase in false‐negative cytological findings before cancer diagnoses. Years later, we performed a long‐term follow‐up to investigate whether the problem persisted. At each calendar year from 2016 to 2020, we identified women with prior normal cervical screening results through linkage to the Swedish National Cervical Screening Registry. We reported their incidence rates (IRs) of invasive cervical cancer in consecutive years and compared the IRs over time. For the years 2016 to 2020, there was no overall change in cervical cancer incidence after two normal cytology in the last two screening intervals. However, there was a further 62% increase among women 50 to 60 years of age with normal cytology in the past two screening intervals. The incidence rate of cervical cancer was high among nonscreened women and low among HPV‐screened women with negative results, with no trends over time. Our results imply that the previously reported decrease in sensitivity of cervical cytology is persisting. Although primary cytology screening is no longer used, cytology is used in triaging among HPV‐positive women. Our findings suggest that improved triaging is needed, for example, improved quality assurance and/or use of alternative triage tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
- Department of Pathology and Cancer Diagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital, Stockholm, Sweden.
- Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Regional Cancer Centre West Region Västra Götaland, Gothenburg, Sweden.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Centre for Research and Development, Uppsala University/Region of Gävleborg, Gävle, Sweden.
ORCID-Profile: Jiangrong Wang, Joakim Dillner
Förderung
- Swedish Cancer Foundation
Zitieren
APA
Wang, J., Edvardsson, H., Strander, B., Andrae, B., Sparén, P., & Dillner, J. (2024). Long‐term follow‐up of cervical cancer incidence after normal cytological findings. International Journal of Cancer. https://doi.org/10.1002/ijc.34723
Vancouver
Wang J, Edvardsson H, Strander B, Andrae B, Sparén P, Dillner J. Long‐term follow‐up of cervical cancer incidence after normal cytological findings. International Journal of Cancer. 2024. doi:10.1002/ijc.34723
BibTeX
@article{Wang2024,
author = {Wang, Jiangrong and Edvardsson, Henrik and Strander, Björn and Andrae, Bengt and Sparén, Pär and Dillner, Joakim},
title = {Long‐term follow‐up of cervical cancer incidence after normal cytological findings},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34723}
}
EUVIMED